EMUDHRA:NSE:NSE-eMudhra Limited (INR)

COMMON STOCK | Software - Application |

Last Closing

USD 862.25

Change

-9.65 (-1.11)%

Market Cap

USD 71.52B

Volume

0.22M

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

eMudhra Limited provides trust and enterprise solutions to individuals and organizations worldwide. The company provides enterprise signing solutions, such as emSinger enterprise signing suite, esign, digital stamp, and eBG; digital security solutions, which include emCA-certifiying solutions, identity and access management, multi-factor authentication, and CLM; digital trust services including private trust services, SSL/TL, code signing, email encryption, document signing, and IoT certificates, as well as emsign CertHub; and emSign managed services. It offers emSinger enterprise and emSinger for banks; bulksign; and remote sign as-a-services. It serves banking, government, manufacturing, healthcare, aviation, QTSP, telecom, enterprise, and electric vehicles industries. The company was incorporated in 2008 and is based in Bengaluru, India.

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-09-26 )

Largest Industry Peers for Software - Application

Symbol Name Price(Change) Market Cap
TATAELXSI:NSE Tata Elxsi Limited

+5.20 (+0.07%)

USD 475.96B
KFINTECH:NSE Kfin Technologies Limited

-54.40 (-4.98%)

USD 187.26B
NEWGEN:NSE Newgen Software Technologies L..

+27.75 (+2.13%)

USD 169.71B
INTELLECT:NSE Intellect Design Arena Limited

+12.70 (+1.25%)

USD 135.13B
TANLA:NSE Tanla Platforms Limited

+1.70 (+0.19%)

USD 126.19B
RATEGAIN:NSE Rategain Travel Technologies L..

-7.75 (-1.05%)

USD 86.73B
BBOX:NSE Black Box Limited

-17.25 (-3.25%)

USD 85.72B
QUICKHEAL:NSE Quick Heal Technologies Limite..

-14.95 (-2.32%)

USD 37.13B
NUCLEUS:NSE Nucleus Software Exports Limit..

+1.25 (+0.10%)

USD 34.27B
GENESYS:NSE Genesys International Corporat..

-6.15 (-0.78%)

USD 30.95B

ETFs Containing EMUDHRA:NSE

N/A

Market Performance

  Market Performance vs. Industry/Classification (Software - Application) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 89.01% 93% A 90% A-
Dividend Return 0.27% 22% F 23% F
Total Return 89.28% 93% A 90% A-
Trailing 12 Months  
Capital Gain 78.85% 59% D- 74% C
Dividend Return 0.26% 22% F 17% F
Total Return 79.11% 63% D 74% C
Trailing 5 Years  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Average Annual (5 Year Horizon)  
Capital Gain 46.96% 37% F 63% D
Dividend Return 47.15% 37% F 62% D
Total Return 0.19% 30% F 20% F
Risk Return Profile  
Volatility (Standard Deviation) 55.67% 81% B- 43% F
Risk Adjusted Return 84.69% 78% C+ 67% D+
Market Capitalization 71.52B 72% C 68% D+

Annual Financials (INR)

Quarterly Financials (INR)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior risk adjusted returns

This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.

Superior return on assets

The company management has delivered better return on assets in the most recent 4 quarters than its peers, placing it in the top quartile.

Low volatility

The stock’s annual returns have been stable and consistent compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile. Although stability is good, also keep in mind it can limit returns.

Positive cash flow

The company had positive total cash flow in the most recent four quarters.

Positive free cash flow

The company had positive total free cash flow in the most recent four quarters.

Superior Revenue Growth

This stock has shown top quartile revenue growth in the previous 5 years compared to its sector.

What to not like:
Overpriced on cashflow basis

The stock is trading high compared to its peers on a price to cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.

Overpriced compared to book value

The stock is trading high compared to its peers median on a price to book value basis.

Overpriced compared to earnings

The stock is trading high compared to its peers on a price to earning basis and is above the sector median.

Below median dividend returns

The company’s average income yield over the past 5 years has been low compared to its peers. However, it is not a problem if you are not looking for income.

Below median total returns

The company has under performed its peers on annual average total returns in the past 5 years.

Overpriced on free cash flow basis

The stock is trading high compared to its peers on a price to free cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.